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Alcoholic liver disease encompasses a wide spectrum of pathogenesis including steatosis, ﬁbrosis,
cirrhosis, and alcoholic steatohepatitis. Autophagy is a lysosomal degradation process that degrades
cellular proteins and damaged/excess organelles, and serves as a protective mechanism in response to
various stresses. Acute alcohol treatment induces autophagy via FoxO3a-mediated autophagy gene
expression and protects against alcohol-induced steatosis and liver injury in mice. Farnesoid X Receptor
(FXR) is a nuclear receptor that regulates cellular bile acid homeostasis. In the present study, wild type
and FXR knockout (KO) mice were treated with acute ethanol for 16 h. We found that ethanol treated-
FXR KO mice had exacerbated hepatotoxicity and steatosis compared to wild type mice. Furthermore, we
found that ethanol treatment had decreased expression of various essential autophagy genes and several
other FoxO3 target genes in FXR KO mice compared with wild type mice. Mechanistically, we did not ﬁnd
a direct interaction between FXR and FoxO3. Ethanol-treated FXR KO mice had increased Akt activation,
increased phosphorylation of FoxO3 resulting in decreased FoxO3a nuclear retention and DNA binding.
Furthermore, ethanol treatment induced hepatic mitochondrial spheroid formation in FXR KO mice but
not in wild type mice, which may serve as a compensatory alternative pathway to remove ethanol-
induced damaged mitochondria in FXR KO mice. These results suggest that lack of FXR impaired FoxO3a-
mediated autophagy and in turn exacerbated alcohol-induced liver injury.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-SA
license (http://creativecommons.org/licenses/by-nc-sa/3.0/).Introduction
Alcohol is widely consumed in the United States and world-
wide, and could be beneﬁcial in moderate amount. Excessive
alcohol consumption and abuse may result in alcoholic liver
disease (ALD), a major contributor of liver diseases and deaths
[1,2]. Pathogenesis of ALD initiates with simple steatosis in a
majority of drinkers and progresses to more severe pathologies
including ﬁbrosis, alcoholic hepatitis, and cirrhosis in a fraction ofB.V. This is an open access article u
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SA.patients. In exceptional cases, ALD may progress to hepatocellular
carcinoma [2]. Binge drinking is a form of alcohol abuse deﬁned by
consuming more than 5 drinks (males) or 4 drinks (females) in 2 h
setting [3]. Around one out of three adults display high risk
drinking pattern including binge drinking, but less attention has
been given to liver injury induced by acute alcohol exposure
despite the fact binge drinking is more common than chronic
alcohol abuse [1]. At the physiological level, binge drinking
induces glycogen depletion, acidosis, and hypoglycemia [4]. At
the cellular level, binge drinking results in mitochondria damage,
ablated insulin signaling, steatosis, and free radical generation
[5–9]. Paradoxically, binge drinking induces autophagy as a cel-
lular protective mechanism to selectively degrade damaged mi-
tochondria (mitophagy) and lipid droplets (lipophagy), whereas
suppression of autophagy by pharmacological inhibitors or small
interfering RNAs exacerbates alcohol-induced hepatotoxicity and
steatosis [10,11].
Autophagy is a cellular lysosomal degradation pathway respon-
sible for degradation of cellular protein and damaged organelles to
promote cell survival [12]. The autophagy process is characterized
by formation of circular double membrane autophagosomes
containing containing cargo. Autophagosomes then fuse withnder the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
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autophagic cargo [12]. More than 30 Atg genes have been identi-
ﬁed to participate in autophagy in yeast, and most of them have
mammalian homologs [13]. Among them, two ubiquitin conjuga-
tion systems include Atg7 (E1-like protein), Atg3 (E2-like) and
Atg5-Atg12-Atg16 complex (E3 ligase) play an essential role to
mediate the conjugation of phosphatidylethanolamine (PE) to
microtubule associated protein light chain 3 (LC3) [14,15]. This
conjugated form of LC3 is known as LC3-II, and the unconjugated
form of LC3 is referred to as LC3-I [16]. LC3-II is targeted to the
autophagosomal membrane. After an autophagosome fuse with a
lysosome, the inner membrane LC3-II on an autolysosome is
degraded and the outer membrane LC3-II is de-conjugated by
Atg4B and recycled [17]. Induction of autophagy or inhibition of
autophagy degradation causes LC3-II accumulation; therefore,
LC3-II is used as a marker to monitor autophagic ﬂux [18].
Sequestome-1 (Sqstm1)/p62 is another speciﬁc autophagy sub-
strate that also can be used to monitor autophagic ﬂux, and is
accumulated in autophagy deﬁcient cells or mouse liver [19–21].
FoxO3a is a member of the FoxO transcription factor family, and
regulates the transcription of genes involved in apoptosis, oxida-
tive stress, cell-cycle transition and DNA repair [22,23]. FoxO3a
also regulates the expression of autophagy genes in skeletal
muscles [24,25], cardiomyocytes [26], and liver [27]. Multiple
post-translational modiﬁcations including phosphorylation, ubi-
quitination, acetylation and methylation regulate the FoxO3a
cellular localization and DNA-binding afﬁnity [22,23]. Akt is the
canonical regulator of FoxO3a by phosphorylating FoxO3a on
serine 253 and sequestering FoxO3a in the cytosol, which renders
FoxO3a unable to bind with DNA and induce gene transcription
[22]. We have recently demonstrated that acute ethanol treatment
inhibits Akt-mediated phosphorylation of FoxO3 resulting in
nuclear FoxO3a retention and increased transcription of autop-
hagy genes in mouse livers and primary mouse and human
hepatocytes [27].
Farnesoid X receptor (FXR), the master regulator of bile acid
homeostasis, is a member of the nuclear hormone receptor super-
family that is highly expressed in liver and intestines [28–30]. Bile
acids are identiﬁed as the endogenous ligands for FXR, and bile
acid-mediated FXR activation increases the expression of SHP,
which serves as a negative regulator of bile acid synthesis. As a
result, FXR knockout (KO) mice display elevated hepatic bile acid
level due to the lack of SHP-mediated inhibition on bile acid
synthesis [29,30]. We recently demonstrated that FXR KO mice
display impaired hepatic autophagy due to increased hepatic bile
acid level. Furthermore, bile acids suppress autophagosomal–
lysosomal fusion [31]. Recent studies showed that activation of
FXR protected against ethanol-induced hepatotoxicity and steato-
sis [32,33]. However, whether FXR would play a role in ethanol-
induced autophagy is not known.
In the present study, we found that FXR was critical for
protecting against acute ethanol-induced hepatotoxicity and stea-
tosis by promoting ethanol-induced nuclear FoxO3a retention and
activation. In response to acute ethanol treatment, there was an
increased Akt activation resulting in decreased nuclear FoxO3a
retention and FoxO3a-mediated expression of autophagy genes in
FXR KO mice. Acute ethanol treatment also promoted mitochon-
drial spheroid formation in FXR KO mouse livers.Materials and methods
Reagents
The following antibodies were used: p62 (H00008878-M01)
from Abnova (Taipei, Taiwan), Beclin-1 (sc11427), FXR (sc13063),and HA (sc805) from Santa Cruz Biotechnology (Santa Cruz, CA),
and Flag (F3165) from Sigma (St. Louis, MO), serine 473 phos-
phorylated Akt (4058), Akt (9272), serine 9 phosphorylated GSK3β
(5558S), GSK3β (5676S), serine 253 phosphorylated FoxO3a,
FoxO3a (2497), GAPDH (2118), and Lamin A/C (2032) from Cell
Signaling Technology (Beverly, MA), and CYP2E1 (ab28146) from
Abcam (Cambridge, MA). The rabbit polyclonal anti-LC3B antibody
was described previously [34]. The secondary antibodies used for
immunoblotting analysis were HRP-conjugated goat anti-mouse
(115-035-062), rabbit (111-035-045), and rat (111-035-143) and a
Dylight 549 conjugated goat anti-rabbit (111-505-144) antibody
from Jackson ImmunoResearch (West Grove, PA) or an HRP-
conjugated goat anti-rabbit antibody (31460) from Thermo Fisher
Scientiﬁc (Waltham, MA). Ethanol was from Pharmaco (Brookﬁeld,
CT). All other chemicals were from Sigma-Aldrich, (St. Louis, MO),
Thermo, Fisher Scientiﬁc (Waltham, MA), Invitrogen (Carlsbad,
CA), or EMD Millipore (Billerica, MA).
Animal experiments
Wild type C57BL and FXR KO C57BL were purchased from
Jackson Laboratory (Bar Harbor, ME). 2–4 months age matched
male wild type and FXR KO mice were used in this study. All mice
were provided with humane care according to the NIH guidelines,
and the Institutional Animal Care and Use Committee at the
University of Kansas Medical Center approved all procedures.
Mouse ethanol binge treatment
The ethanol binge model was modiﬁed from the model Carson
and Pruett established, which had been shown to closely mimic
human binge ethanol consumption including blood alcohol levels
and behavioral effects [35]. The mice were fasted for 6 h, and then
administered with 33% (v/v) ethanol at a cumulative dose of 4.5 g/
kg body weight by four equally divided gavages in 15 min inter-
vals. Control mice received same volume of double-distilled water.
Mice were sacriﬁced 16 h later after the treatment, and serum and
liver samples were harvested. Serum alanine aminotransferase
(ALT) levels and H&E staining were used to assess ethanol-induced
liver injury. Total liver lysates were obtained by using radio-
immunoprecipitation assay buffer (1% NP40, 0.5% sodium deox-
ycholate, 0.1% sodium dodecyl (lauryl) sulfate).
Cell culture and transfection
Human embryonic kidney 293A cells were cultured in DMEM
medium with FBS and L-glutamate and transiently transfected
with HA tagged FoxO3, Flag tagged FXR, HA or Flag plasmid
constructs using TurboFect Transfection reagent (Thermo, Fisher
Scientiﬁc) for 24 h. Total cell lysates then were extracted using HA
cell lysis buffer (50 mM Tris–HCl pH 7.5, 150 mM NaCl, 2 mM EDTA
pH 7.5, 1 mM EGTA pH 7.5, 1% Triton X-100, protease inhibitors).
Hepatic triglyceride analysis
Frozen liver tissues (50–100 mg) were grounded to ﬁne powder
using mortar and pestle. The powdered tissue was incubated in
1 ml of chloroform:methanol (2:1) mix with vigorous shaking for
1 h at room temperature. 200 ml of double-distilled water was
added, and the mixture was centrifuged for 5 min at 3000g at 4 °C.
The aqueous upper phase layer then was collected and air-dried at
room temperature. The dried pellet was dissolved in tert-butanol
and Triton X-114:methanol (2:1) solution. Hepatic triglyceride
analysis was performed with a colormetric assay kit according to
manufacturer’s instruction (Pointe Scientiﬁc, Ann Arbor, MI).
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Equal amount of nuclear fraction (15 mg), cytosol fraction
(30 mg), or total liver lysates (50 mg) were separated by SDS-PAGE
gel and transferred to PVDF membranes. The membranes were
immunoblotted with primary antibodies followed by HRP-conju-
gated secondary antibodies. The membranes then were developed
with either Pierce Supersignal West Pico chemiluminescent sub-
strate (Thermo, Fisher Scientiﬁc, Rockford, IL) or Millipore Im-
mobilon Western chemiluminescent HRP substrate (Billerica, MA).
Densitometry was performed using ImageJ software and further
normalized using beta-actin or GAPDH, and expressed as
means7SEM.
qPCR
RNAwas isolated from liver tissues using TRIzol (Life Technologies,
Waltham, MA) and reversed transcribed into cDNA by RevertAid
reverse transcriptase (Thermo, Fisher Scientiﬁc, Waltham, MA). Real-
time PCR was performed on a Bio-Rad CFX384™ real-time PCR
detection system using iTaq™ Universal SYBRs Green Supermix
(Bio-Rad). The following genes were probed with quantitative PCR
using β-actin gene as loading control: Atg5, Becn-1,Map1lc3b,MnSOD,Fig. 1. FXR KO mice exhibited increased ethanol-induced liver injury and steatosis. Age m
for 16 h. Serum alanine aminotransferase (ALT) (A) and hepatic triglycerides (TG) (B)
representative oil red o images are shown in (D). Representative EM images are shown
* po0.05. One-way ANOVA analysis. FXR KO control vs WT control, FXR KO ethanol vsp21, FoxO3a, Sqstm-1, and Shp. Primer sequences were as follows: β-
actin, 5′-TGTTACCAACTGGGACGACA-3′ and 5′-GGGGTGTTGAAGGTCT-
CAAA-3′; Atg5, 5′-GACCACAAGCAGCTCTGGAT-3′ and 5′-GGTTTCCAG-
CATTGGCTCTA-3′; Becn-1 (Atg6), 5′-TGATCCAGGAGCTGGAAGAT-3′
and 5′-CAAGCGACCCAGTCTGAAAT-3′; FoxO3a, 5′-AGCCGTGTACTGTG-
GAGCTT-3′ and 5′-TCTTGGCGGTATATGGGAAG-3′; Map1lc3, 5′-CCGA-
GAAGACCTTCAAGCAG-3′ and 5′-ACACTTCGGAGATGGGAGTG-3′;
MnSod, 5′-GGCCAAGGGAGATGTTACAA-3′ and 5′-AGACACGGCTGT-
CAGCTTCT-3′; p21, 5′-CGGTGGAACTTTGACTTCGT-3′ and 5′-CAGGGCA-
GAGGAAGTACTGG-3′; Sqstm1/p62, 5′-AGAATGTGGGGGAGAGTGTG-3′
and 5′-TCGTCTCCTCCTGAGCAGTT-3′; and Shp, 5′-CTGCAGGTCGTCC-
GACTATT-3′ and 5′-ACCTCGAAGGTCACAGCATC-3′.Immunoprecipitation
Total cell lysates (200 mg) or total liver lysates (500 mg) were
incubated with a FoxO3a antibody (sc11351, Santa Cruz) overnight
at 4 °C rotating and pulled down with protein A/G agarose beads
(sc2003, Santa Cruz) or EZview™ Red ANTI-FLAGsM2 Afﬁnity Gel
(F2425, Sigma). Immunoblot analysis was performed with immu-
noprecipitated and input proteins.atched WT and FXR KO mice were treated with 4.5 g/kg ethanol or water by gavage
were measured (n¼4–9). Representative H&E stain images are shown in (C) and
in (E) and lipid droplets (LD) are quantiﬁed from at least 24 different liver sections.
WT ethanol (A). WT ethanol vs control, and FXT KO ethanol vs control (B).
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Fresh liver sections were minced or frozen liver sections were
homogenized and cross-linked with 1% formaldehyde in PBS. Follow-
ing incubation, the livers were quenched with 250mM glycine. Crude
nuclear extracts were obtained using hypotonic buffer (10 mM Tris–
HCl pH 8.0, 10 mM NaCl, 3 mM MgCl2, 0.5% NP-40) and nuclear lysis
buffer (1% SDS, 5 mM EDTA, 50 mM Tris–HCl pH 8.0). The chromatin
extracts then were sheared using Active Motif Q800R sonicator to
200–500 bp fragments. Chromatin proteins (600 mg) were immuno-
precipitated with a FoxO3a antibody (sc11351X) from Santa Cruz
Biotechnology (Santa Cruz, CA) binded with Dynabead Protein A
(10001D) from Invitrogen/Dynal (Oslo, Norway). DNA then was
extracted from immunoprecipiated and input chromatin using Gene-
Jet PCR Puriﬁciation Kit (K0701) from Thermo Scientiﬁc (Waltham,
MA). qPCR was performed and three FoxO3a binding sites in the
Map1LC3b promoter site were probed. Primer sequences were as
follows: 1379–1608 bp upstream, 5′-CATGCCTTGGGACACCAGAT-3′
and 5′-ACCTTCTTCAAGTGCTGTTTGT-3′; 3397–3595 bp upstream, 5′-
TTTGACCAAACAGGGTTTCC-3′ and 5′-CCCTCCAGGTGTTTGTGATAA-3′;
and 4673–4801 bp upstream, 5′-CCTCAGCTGGCTAAGAGCAT-3′ and 5′-
CCC AAG GAT CTC AAC CAA AC-3′. The primer sequences were
obtained from a previous report [24].
Fluorescence and electron microscopy
Liver sections were ﬁxed with 4% paraformaldehyde then
incubated in 20% sucrose in PBS and embedded in optimal cutting
temperature (OCT) solution at 20 °C. Liver cyrosections were
immunostained with FoxO3a antibody followed by Dylight 549
conjugated secondary antibody and Hoechst 33342 staining. The
images of sections were acquired under a Nikon Eclipse 200
ﬂuorescence microscope with MetaMorph software. For electronFig. 2. Ethanol induced p62 and LC3-II protein expression was enhanced in FXR KO mice
gavage for 16 h. Total liver lysates were subjected to immunoblot analysis for p62 and LC
(n¼3–4). Hepatic mRNA was isolated and qRT-PCR was performed for p62 (C). The gene
type mice (n¼4–7). Representative EM images are shown in (D). Right image is the enlar
arrows: autolysosomes (Avd) (D). Autophagosomes (Avi) and autolysosomes (Avd) were
FXR ethanol vs WT ethanol (E).microscopy (EM), liver sections were ﬁxed with 2.5% glutaralde-
hyde in 0.1 mol/l sodium cacodylate buffer (pH 7.4), followed by
1% OsO4. After dehydration, thin sections were cut and stained
with uranyl acetate and lead citrate. Digital images were obtained
using a JEM 1016CX electron microscope.
Nuclear fractionation
Mouse liver cytosol and nuclear proteins were extracted using
NE-PER nuclear and cytoplasmic extraction reagents (Thermo,
Fisher Scientiﬁc) according to manufacturer's instructions. In brief,
50–100 mg of liver was homogenized in cytoplasmic extraction
reagent I followed by addition of cytoplasmic extraction reagent II
and centrifuged. The supernatant was collected as cytoplasmic
fraction, and the insoluble pellet was suspended in nuclear
extraction reagent and centrifuged. The resulting supernatant
contains nuclear fraction.
Statistic analysis
All experimental datawere expressed as means7SE and subjected
to Student t-test or one-way analysis of variance with Holm–Sidak
post hoc test or one-way analysis of variance on ranks with Dunn post
hoc test where appropriate. *po0.05 was considered signiﬁcant.Results
Acute ethanol treatment exacerbated liver injury and steatosis in FXR
KO mice compared to WT mice
Acute ethanol treatment increased serum alanine aminotrans-
ferase (ALT) levels and hepatic triglyceride levels in wild type (WT). Age matched WT and FXR KO mice were treated with 4.5 g/kg ethanol or water by
3 (A) and CYP2E1 (B). Densitometry analysis data are presented as a ratio of control
expression levels were normalized to β-actin and shown as fold increase over wild
ged image from the box area. White arrows: early autophagosomes (Avi) and yellow
quantiﬁed (E) (o24 different liver sections). *po0.05. One-way ANOVA analysis.
Fig. 3. Ethanol-induced FoxO3a-mediated transcription of autophagy related and
FoxO3a target genes were inhibited in FXR KO mouse livers. Age matched WT and
FXR KO mice were treated with 4.5 g/kg ethanol or water by gavage for 16 h.
Hepatic mRNA was isolated and qRT-PCR was performed for autophagy related
genes, Atg5, Becn-1, and MAP1LC3B (A) and FoxO3a target genes, MnSOD, p21, and
FoxO3a (B). qRT-PCR was also performed for FXR target gene, Shp (C). The gene
expression levels were normalized to β-actin and shown as fold increase over wild
type mice (n¼4–7). *po0.05. One-way ANOVA analysis. WT control vs FXR KO
control, WT ethanol vs FXO KO ethanol.
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to WT mice, acute ethanol-treated FXR KO mice had higher serum
ALT and hepatic triglyceride levels, suggesting ethanol treatment
exacerbated liver injury and steatosis in FXR KO mice (Fig. 1A and
B). Notably, control FXR KO mice already had a mild increase of
serum ALT level, which is consistent with previous reports
suggesting the lack of FXR causes mild liver injury [36] (Fig. 1A).
However, there was no difference in hepatic triglycerides level
between age matched WT and FXR KO control mice (Fig. 1B).
Hematoxylin and eosin staining revealed that ethanol induced
mild hepatic steatosis in WT mice, which was further exacerbated
in FXR KO mice (Fig. 1C). In line with these ﬁndings, oil red o
staining for lipids showed that ethanol-treatment increased oil red
o staining in WT mouse livers compared to control mice. However,
oil red o staining was much more severe in ethanol-treated FXR
KO mouse livers compared to ethanol-treated WT mouse livers,
suggesting that lack of FXR exacerbates ethanol-induced hepatic
steatosis (Fig. 1D). Furthermore, EM analysis also revealed that
ethanol treatment increased the number of lipid droplets in WT
mouse livers. The number of lipid droplets was further increased
in ethanol-treated FXR KO mouse livers compared to WT mouse
livers (Fig. 1E and F). Taken together these data indicate that FXR
deﬁciency exacerbates acute ethanol-induced liver injury and
steatosis.
Impaired autophagy in acute ethanol-treated FXR KO mouse livers
We previously demonstrated that FXR KO mice have impaired
hepatic autophagy [31]. In accordance with previous ﬁndings, we
showed that control FXR KO mice had higher basal LC3-II and p62
protein levels compared to WT mice. Ethanol treatment increased
LC3-II protein levels in WT but not in FXR KO mouse livers
(Fig. 2A). However, ethanol treatment increased p62 protein levels
in WT mouse livers, which was further increased in FXR KO mouse
livers (Fig. 2A). Ethanol treatment also increased CYP2E1 protein
levels in both WT and FXR KO mouse livers (Fig. 2B), consistent
with previous reports [37]. Ethanol treatment increased the mRNA
levels of p62 in WT mouse livers but not in FXR KO mouse livers
(Fig. 2C), suggesting that ethanol treatment-increased p62 protein
levels could be mediated by the increased transcription for p62 in
WT mice whereas increased p62 levels in FXR KO mice were
mainly regulated at the protein level. EM analysis revealed that
ethanol treatment increased the number of autolysosomes in WT
mouse livers although it did not reach the statistical signiﬁcance.
Consistent with our previous report [31], control FXR KO mice
already had increased number of autophagosomes and autolyso-
somes likely due to impaired fusion of autophagosomes with
lysosomes. Treatment with acute ethanol further increased the
number of autophagosomes and autolysosomes (Fig. 2D and E).
These results indicate that autophagy was impaired in FXR KO
mouse livers, which might contribute to exacerbated liver injury
and steatosis following ethanol treatment.
Lack of FXR impaired acute ethanol-induced FoxO3a activation.
We previously reported that acute ethanol treatment induces
FoxO3a-mediated hepatic expression of autophagy related genes
[27]. Consistent with our previous report, ethanol treatment
increased the mRNA levels of Atg5, Becn-1 and Microtubule-asso-
ciated protein 1 light chain 3 beta (Map1lc3b) in WT mouse livers
(Fig. 3A). In contrast, ethanol treatment did not cause such an
increase, and actually showed a slight decrease of hepatic expres-
sion of these autophagy related genes in FXR KO mice. In addition
to autophagy related genes, ethanol treatment also increased
expression of MnSod, p21 and FoxO3a, which are known FoxO3a
target genes, in WT but not FXR KO mouse livers (Fig. 3B). Smallheterodimer partner (Shp) is a well-known target gene of FXR, and
ethanol treatment had no effect on the expression of hepatic Shp
mRNA level in WT mice, suggesting that acute ethanol treatment
may not activate FXR. In contrast, FXR KO mice had dramatically
decreased expression of hepatic Shp, which was further decreased
with ethanol treatment (Fig. 3C). These results suggest that lack of
FXR impairs ethanol-induced FoxO3a activation in mouse livers.
No direct interaction between FoxO3a and FXR both in vitro and in
vivo
To determine whether FXR would directly interact with Fox-
O3a, we transiently transfected HA-tagged FoxO3a, Flag-tagged
FXR, or both in human embryonic kidney (HEK) 293A cells
followed by co-immunoprecipitation assay. We found that there
was a weak interaction between Flag-FoxO3a and HA-FXR. How-
ever, Flag tag only also showed similar weak interaction with HA-
FXR, suggesting that the interaction between Flag-FoxO3a and HA-
FXR is none-speciﬁc. Immunoblotting analysis of the total lysate
revealed that the transfection was efﬁcient in HEK293 cells
(Fig. 4A). We further found that FoxO3a was present in both
nuclear and cytosolic fractions, whereas FXR was dominantly
expressed in nuclear fraction, suggesting that the lack of
Fig. 4. FXR and FoxO3a did not interact in vitro or in vivo. HEK 293A cells were transfected with plasmids containing ﬂag-FXR, HA-FoxO3a, HA or ﬂag. Total cell lysates were
isolated, and ﬂag was pulled down by immunoprecipitation and subjected to immunoblot analysis for ﬂag and HA. Input total lysates from transfected HEK 293A were used
as positive controls for FoxO3a and FXR (A). Cytosol and nuclear fractions were obtained from transfected HEK 293A cells, and immunoblot analysis was performed for ﬂag
and FoxO3 (B). Age matched WT and FXR KO mice were treated with 4.5 g/kg ethanol or water by gavage for 16 h. FoxO3a in total liver lysates was pulled down by
immunopreciptation and subjected to immunoblot analysis for FXR and FoxO3a (C).
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tions of cellular localization as a result of the overexpression of
these two proteins (Fig. 4A). To determine whether endogenous
FXR in mouse livers would interact with endogenous FoxO3a, and
whether this interaction would be altered by ethanol treatment,
immunoprecipitation was performed using endogenous liver pro-
teins frommouse livers with or without ethanol treatment. Similar
to the results from the overexpression of FoxO3a and FXR in
HEK293 experiment, no interaction between FoxO3a and FXR was
found in both control and ethanol-treated mouse livers (Fig. 4B).
These results suggest that FXR may not directly interact with
FoxO3a in ethanol-treated mouse livers.
Ethanol-induced FoxO3a nuclear translocation was inhibited in FXR
KO mouse livers
We next determined whether lack of FXR would affect the
cellular localizations of FoxO3a in ethanol treated mouse livers.
Immunostaining analysis for endogenous FoxO3a revealed that
acute ethanol treatment increased the number of cells with
nuclear FoxO3a signals in WT but not in FXR KO mouse livers(Fig. 5A and B). To conﬁrm the ﬁndings from the immunostaining
analysis, cytosolic and nuclear fractions were prepared from WT
and FXR KO mouse livers followed by immunoblotting analysis.
We found that there was a decrease of cytosolic but increase of
nuclear FoxO3a in WT mouse livers after ethanol treatment.
However, acute ethanol treatment failed to increase nuclear
FoxO3a levels in FXR KO mice (Fig. 5C). These data suggest that
acute ethanol-induced nuclear retention of FoxO3a is inhibited in
FXR KO mouse livers.
Acute ethanol treatment increased Akt-mediated FoxO3a
phosphorylation and inhibited ethanol-induced FoxO3 binding in
Map1lc3b promoter sites in FXR KO mouse livers
We found that acute ethanol treatment slightly decreased the
phosphorylation of Akt at serine 473 in WT mouse livers, which is
consistent with our previous report [27]. Conversely, we found
that acute ethanol treatment dramatically increased the phos-
phorylation of Akt in FXR KO mouse livers by ﬁve-fold (Fig. 6A).
Glycogen synthase kinase beta (GSK3β) can be phosphorylated by
Akt and thus serves as an indirect marker for Akt kinase activity.
Fig. 5. Ethanol-induced FoxO3a nuclear translocation was diminished in FXR KO mouse livers. Age matched WT and FXR KO mice were treated with 4.5 g/kg ethanol or
water by gavage for 16 h. Liver cyrosections were immunostained for FoxO3a and Hoechst 33342 for nuclei, and representative images are shown in (A). Nuclei positive for
FoxO3a were quantiﬁed from at least 3 images (B). Cytosolic and nuclear fractions were isolated from liver and subjected to immunoblot analysis for FoxO3a and FXR
(C) densitometry analysis data are presented as a ratio of control (n¼3).
S. Manley et al. / Redox Biology 2 (2014) 991–1002 997We found that the phosphorylation of GSK3β at serine 9 was
reduced in ethanol treated WT mouse livers, but it was enhanced
by ethanol treatment in FXR KO mouse livers by approximately
2.5-fold (Fig. 6A). These data suggest that acute ethanol treatment
inhibits Akt activity in WT mouse livers but increases Akt activity
in FXR KO mouse livers. As a result, we found that ethanol
treatment attenuated the phosphorylation of FoxO3a at serine
253 in WT mouse livers but increased the phosphorylation of
FoxO3a in FXR KO mouse livers (Fig. 6B). Moreover, ethanol
increased total hepatic FoxO3a protein expression in WT mouse
livers by two-fold but decreased the hepatic FoxO3a protein level
in FXR KO mice. Since FoxO3a itself is a target gene of FoxO3a,
these data thus may also imply that there is a decrease of FoxO3a
transcriptional activity in FXR KO mouse livers after ethanol
treatment compared to WT mice. We next performed ChIP
analysis to determine whether there would be any changes for
FoxO3a binding on its target genes between WT and FXR KO
mouse livers after ethanol treatment. It has previously been
reported that FoxO3a binds to mouse Map1lc3b transcription
promoter region in three different sites at approximately 1.5,
3.5 and 4.5 kilo-base pairs upstream of the Map1lc3b transcription
start site [24]. Indeed, ethanol increased FoxO3a binding to all
three binding sites in WT mouse livers, but these bindings were
signiﬁcantly diminished in FXR KO mouse livers (Fig. 6C). Collec-
tively, these data suggest that ethanol treatment activates Akt andincreased phosphorylation of FoxO3a resulting in decreased Fox-
O3a transcriptional activity in FXR KO mouse livers.
Acute ethanol treatment increased the number of mitochondrial
spheroid in ethanol-treated FXR KO mouse livers
We previously reported that mitochondrial spheroids are
induced to serve as an alternative mitochondrial quality control
pathway in response to stresses that induce mitochondrial damage
as a result of impaired conventional mitophagy [38]. In ethanol
treated FXR KO mouse livers, we found that some mitochondria
underwent a dramatic structural remodeling that form a vesicular-
like structure with enveloped contents. Some part of the mito-
chondria formed a four-membrane structure with squeezed matrix
(Fig. 7A, arrows), which is consistent with the formation of
mitochondrial spheroids that we previously reported [38]. We
did not detect any mitochondrial spheroids in either control or
ethanol treated WT mouse livers but quantitative EM analysis
showed increased number of mitochondrial spheroid in control
FXR KO mouse livers, which was further increased after ethanol
treatment (Fig. 7B). These results suggest that acute ethanol
treatment may induce the formation of mitochondrial spheroid
as an alternatively mitochondrial quality control to compensate for
the impaired autophagy in FXR KO mouse livers. We previously
demonstrated that Parkin negatively regulates the formation of
Fig. 6. Increased Akt activity and reduced FoxO3a binding in Map1lc3b promoter
sites in acute ethanol-treated FXR KO mouse livers. Age matched WT and FXR KO
mice were treated with 4.5 g/kg ethanol or water by gavage for 16 h. Total liver
lysates were subjected to immunoblot analysis for serine 473 phosphorylated and
total AKT, serine 9 phosphorylated and total GSK3β (A), and serine 253 phosphory-
lated and total FoxO3a (B). Densitometry analysis data are presented as a ratio of
control (n¼3–4). Chromatin immunoprecipitation using FoxO3a antibody was
performed to probe the three putative FoxO3a binding sites in Map1lc3b promoter
site. DNA was isolated from chromatin pull-down and qPCR analysis was
performed, and data was normalized to input chromatin. Relative binding abun-
dance in comparison to untreated WT control was presented in (C). *po0.05. One-
way ANOVA analysis. WT ethanol vs FXR KO ethanol.
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sin 1 (Mfn1) and Mfn2, two important proteins that regulate
mitochondrial fusion [38,39]. Interestingly, we found that acute
ethanol treatment caused almost 50% loss of hepatic Parkin. While
the mechanisms of how ethanol decreased Parkin protein levels in
the mouse livers were not clear, we have found that chronic plus
binge alcohol treatment (Gao-binge) led to the Parkin mitochon-
drial translocation (Williams J. et al., unpublished observations).
Thus it is possible that the decreased Parkin in acute ethanol-
treated mouse livers was due to the increased autophagic degra-
dation of Parkin positive mitochondria (mitophagy). Interestingly,
we also found that increased degradation of Mfn1 and Mfn2 in
ethanol-treated wild type mouse livers but the levels of Mfn1 and
Mfn2 were less affected in FXR KO mouse livers (Fig. 7C). The
relatively higher levels of Mfn1 and Mfn2 in ethanol-treated FXO
KO mouse livers than that of wild type mice may account for the
increased mitochondrial spheroids formation in FXO KO mouse
livers. We also found that acute ethanol treatment led to approxi-
mately 30% decrease on hepatic Lamp1 and Lamp2 proteins inboth wild type and FXR KO mice (Fig. 7C). Alcohol consumption
has been implicated in impaired lysosomal functions but whether
the decreased Lamp1 and Lamp2 would contribute to the impaired
lysosomal functions need to be further studied. The proposed
cellular mechanisms of how FXR regulates FoxO3 and mitochon-
dria homeostasis are shown in Fig. 8.Discussion
In the present study, using an acute ethanol binge model, we
showed that FXR KO mice had exacerbated steatosis and liver
injury in comparison with WT mice. Mechanistically, following
acute ethanol treatment, FXR KO mice had impaired hepatic
autophagy due to the failure of activating FoxO3a-mediated up-
regulation of autophagy related genes and likely reduced fusion of
autophagosomes with lysosomes.
It is well known that the nuclear receptor FXR is the master
regulator of bile acid homeostasis. FXR deﬁciency caused an
increased concentration of bile acid in liver and serum due to
activation of Cyp7A1 [29,30]. We previously reported that FXR KO
mice had reduced hepatic autophagy likely due to impaired fusion
of autophagosomes with lysosomes as a result of increased hepatic
bile acid levels [31]. In addition to removing cytosolic proteins and
damaged/excess organelles, autophagy has been known to remove
excess lipid droplets, a process named lipophagy [40]. Impaired
autophagy has been reported in many experimental NAFLD and
NASH models, which was associated with endoplasmic reticulum
(ER) stress and post-translational modiﬁcations of several autop-
hagy proteins [1,41]. We also showed that fatty acids differentially
regulated autophagy in which saturated fatty acids suppressed
whereas unsaturated fatty acids induced autophagy in cultured
hepatoma cells [42]. In the context of alcoholic liver diseases, we
also showed that pharmacological inhibition of autophagy exacer-
bated acute ethanol-induced steatosis [10]. Therefore, the im-
paired autophagy in FXR KO mice is likely one of the major
contributors for the exacerbated hepatic steatosis in acute etha-
nol-treated FXR KO mice.
Interestingly, it has been reported that chronic ethanol expo-
sure inhibited FXR activation, resulting in up-regulation of bile
acid synthesis enzymes and down-regulation of bile acid trans-
porter and in turn elevated hepatic bile acid pool [33,43]. More-
over, pharmacological activation of FXR using WAY-362450 and
6α-ethyl-chenodeoxycholic acid (6ECDCA) attenuated chronic
ethanol exposure-induced liver injury and steatosis [32,43]. While
it is still controversial regarding the autophagy status in the mouse
livers after chronic ethanol exposure, it has been suggested that
chronic ethanol exposure may lead to impaired hepatic autophagy
[44,45]. This notion is supported by the observations that chronic
ethanol exposure leads to hepatomegaly [46], accumulated ubi-
quitin positive protein aggregates [47,48] and decreased protein
degradation [49]. In the future, it will be interesting to determine
whether increased bile acid after chronic ethanol exposure would
contribute to impaired hepatic autophagy and alcohol-induced
liver injury.
Emerging evidence supports that transcriptional regulation of
the expression of autophagy related genes is critical in induction of
autophagy in yeast [50,51], Caenorhabditis elegans [52] and mam-
mals [53,54]. Among the several known transcriptional factors that
regulate autophagy, the FoxO family members play critical roles in
regulating expression of autophagy related genes in skeletal
muscle [24,25], cardiomyocyte [26] and liver [55]. In addition,
cytosolic FoxO proteins were also showed to regulate autophagy
independent of their transcriptional activities [56,57]. We recently
demonstrated that FoxO3a is critical for acute ethanol-induced hepatic
autophagy, and plays a protective role against ethanol-induced liver
Fig. 7. Ethanol induced mitochondrial spheroid formation in FXR KO mouse livers. Age matched WT and FXR KO mice were treated with 4.5 g/kg ethanol or water by gavage
for 16 h. Representative EM images of mitochondrial spheroids from FXR KO control (a) and ethanol-treated (b–e) liver sections were shown (A). Arrows denote
mitochondrial spheroids. Mitochondrial spheroid formation was quantiﬁed (424 liver sections) (B). *po0.05. One-way ANOVA analysis. WT ethanol vs FXR KO ethanol. (C)
Mice were treated as in (A), total liver lysates were subjected to western blot analysis followed by densitometry analysis. Densitometry analysis data are presented as a ratio
of control (n¼3–4).
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ethanol induced FoxO3a-mediated expression of autophagy related
genes in WT mouse livers. The activation of FoxO3a is mainly
regulated by its post-translational modiﬁcations including phosphor-
ylation, acetylation, ubiquitination and methylation. It has been well-
documented that FoxOs are phosphorylated by the serine/threonine
protein kinase AKT and become sequestered in the cytoplasm, where
they are unable to regulate gene expression [22]. In WT mice, we
found that acute ethanol treatment decreased the level of phosphory-
lated AKT and FoxO3a and in turn increased nuclear retention of
FoxO3a. In contrast, acute ethanol treatment increased AKT activity
resulting in the increased phosphorylation of FoxO3a and decreased
nuclear retention FoxO3a in FXR KOmice. Currently it is not clear how
AKT was activated in FXR KO mouse livers. However, FXR KO micedevelop spontaneous hepatocellular carcinoma [36], and increased
AKT activity can promote tumorigenesis [58]. In addition to post-
translational modiﬁcations, FoxO family members bind to a variety of
nuclear hormone receptors to regulate either their own or nuclear
hormone receptors' DNA binding afﬁnity and transcriptional activities
[59]. FoxO3a contains LxxLL motif in the C-terminal of forkhead DNA
binding region, which may enable FoxO3a to interact with nuclear
hormone receptors [59,60]. Thus it is possible that the decreased
FoxO3a-mediated expression of autophagy related genes is due to the
lack of a direct interaction between FoxO3a and FXR. However, the
failure to detect the direct interaction between FXR and FoxO3a both
in vitro and in vivo excludes this possibility. In addition, we also found
that acute ethanol treatment increased the binding of FoxO3a to the
promoter regions of Map1lc3b in WT but not in FXR KO mouse livers
Fig. 8. Possible molecular and cellular events following acute ethanol treatment in FXR KO mouse livers. Acute ethanol exposure induces FoxO3a activation and mitophagy
as a protective mechanism. FXR deﬁciency promotes Akt activation and subsequent serine 253 phosphorylation of FoxO3a, resulting in decreased nuclear FoxO3a retention
and abolished transcription of autophagy related genes in response to ethanol. The defective hepatic autophagy in FXR KO mouse livers results in impaired mitophagy and
compensatory induction of mitochondrial spheroid formation. Altogether, impaired FoxO3a-mediated autophagy and mitophagy in ethanol-treated FXR KO mouse livers
lead to increased liver injury and steatosis.
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ethanol-treated WT mouse livers could contribute to these observa-
tions, it is also likely that other FoxO3a co-factors/suppressors may
inﬂuence the binding of FoxO3a to the promoter regions ofMaplc3b. It
is known that FoxO3a also interacts with other co-factors such as
PGC1-α [61–63] and p300/CBP [64]. Future studies will be needed to
determine the changes of the interactions of FoxO3a with PGC1-α or
p300/CBP after ethanol treatment in WT and FXR KO mice.
In addition to the defect of FoxO3a-mediated transcriptional
regulation of autophagy in FXR KO mouse livers, increased bile
acid levels may also contribute to the impaired autophagy in FXR
KO mouse livers. As we previously demonstrated that bile acids
themselves did not have any effects on the expression of autop-
hagy related genes regardless of the conjugated or unconjugated
bile acids [31]. However, bile acids impaired the fusion of autop-
hagosomes with lysosomes through the alteration of intracellular
Rab7, a key protein that regulates the fusion of autophagosomes
with lysosomes [31]. The increased number of autophagosomes in
ethanol-treated FXR KO mouse livers may reﬂect the impaired
fusion of autophagosomes with lysosomes. Thus it is likely that the
combination of impaired FoxO3a-mediated expression of autop-
hagy related genes and bile acid-mediated defect on the fusion of
autophagosomes with lysosomes contribute to the exacerbated
steatosis and liver injury in ethanol-treated FXR KO mice.
It is known that alcohol consumption can lead to increased
oxidative stress and mitochondrial damage [1,65]. Metabolism of
alcohol may play a critical role in alcohol-induced oxidative stress
and mitochondrial damage. Alcohol is mainly metabolized in the
liver through cytosolic alcohol dehydrogenase (ADH) to acetalde-
hyde, a highly reactive molecule that is further metabolized
through mitochondrial acetaldehyde dehydrogenase (ALDH) to
acetate. Consequently, alcohol metabolism increases hepatic
NADH/NADþ ratio and oxidative stress. Moreover, alcohol can
also induce hepatic Cyp2E1 expression to oxidize alcohol, which
also leads to increased oxidative stress and mitochondrial damage
[66]. Previous works including ours have shown that the metabo-
lism of alcohol either via AHD or Cyp2E1 is important for alcohol-induced changes on hepatic autophagy [10,67,68]. Interestingly,
we found that the levels of hepatic Cyp2E1 were much higher
induced by acute ethanol treatment in FXR KO mice than wild type
mice. It is likely that the higher levels of Cyp2E1 in FXR KO mouse
livers may also contribute to the increased liver injury by acute
ethanol treatment. Future studies will be needed to further
determine the levels of hepatic oxidative stress after ethanol
treatment in FXR KO mice.
We previously demonstrated that at least one purpose of acute
ethanol-induced autophagy is to remove damaged mitochondrial
through mitophagy [10,11]. However, increased evidence suggests
that cells may use alternative pathways or activate other forms of
autophagy (i.e. microautophagy or chaperone-mediated autop-
hagy) to regulate cellular organelle homeostasis [69]. We recently
reported that several mitochondrial damage stressors induce the
formation of mitochondrial spheroid likely as an alternative path-
way to regulate mitochondrial homeostasis in cultured cells or
mouse livers in both WT and autophagy-deﬁcient cells [38,70].
Interestingly, we also found that acute ethanol treatment in-
creased the number of mitochondrial spheroid in FXR KO but
not WT mouse livers. Moreover, mitochondrial spheroid structures
were also found in the control FXR KO mouse livers. It is likely that
increased bile acid levels might induce mitochondrial damage in
control FXR KO mouse livers, which was further exacerbated after
ethanol treatment. Damaged mitochondria can normally be re-
moved via mitophagy but this process was impaired in FXR KO
mouse livers. The increased mitochondrial spheroid in ethanol-
treated FXR KO mouse livers thus may also serve as an alternative
pathway to regulate mitochondrial homeostasis in FXR KO mouse
livers.
In conclusion, we demonstrated that FXR is a protective factor
against ethanol-induced hepatotoxicity and steatosis. Further-
more, we also showed that FXR is associated with ethanol-induced
FoxO3a activation and FoxO3a-mediated autophagy. Modulating
FXR activity may be a promising novel therapeutic target for ALD.
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